Bibliography
Export 16 results:
Filters: Keyword is Neoplasms / *etiology [Clear All Filters]
How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant. 2010;10(6):1437-44.
Donor derived malignancy following transplantation: a review. Cell Tissue Bank. 2007;8(4):267-86.
Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74(10):1409-13.
Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 2001;130(4):660-6; - discussion - 666-8.
Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg. 1996;2(1):52-9.
De novo malignancy in pediatric organ transplant recipients. J Pediatr Surg. 1994;29(2):221-6; - discussion - 227-8.
The changing pattern of posttransplant malignancies. Transplant Proc. 1991;23(1 Pt 2):1101-3.
Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1990:53-62.
Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev. 1988;12(40695):39-57.
Secondary malignancies after marrow transplantation. Exp Hematol. 1984;12(8):660-6.
Tumor incidence in human allograft recipients. Transplant Proc. 1979;11(1):1047-51.
Tumors in allograft recipients. N Engl J Med. 1979;301(7):385.
Malignant neoplasms following cardiac transplantation. Jama. 1978;240(7):639-43.
Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977;9(1):1121-7.
Malignancies associated with renal transplantation. Urology. 1977;10(1 Suppl):57-63.
Malignancies in recipients of organ transplants. Johns Hopkins Med J Suppl. 1974;3:211-21.